Introduction of calpain inhibitors in traumatic brain injury: A novel approach?

Medical Hypotheses

Volumn 79, Issue 3, 2012, Pages 358-360

  Bralic, Marina ^a   Stemberga, Valter ^b   Stifter, Sanja ^b  

^a KBC RIJEKA   (Croatia)

^b UNIVERSITY OF RIJEKA   (Croatia)

Author keywords

[No Author keywords available]

Indexed keywords

CALPAIN; CALPASTATIN;

ARTICLE; BRAIN DAMAGE; DRUG EFFECT; DRUG EFFICACY; HUMAN; NERVE CELL NECROSIS; NERVE DEGENERATION; NEUROPROTECTION; NONHUMAN; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TRAUMATIC BRAIN INJURY;

ANIMALS; BRAIN INJURIES; CALPAIN; HUMANS; MODELS, THEORETICAL;

ANIMALIA;

EID: 84864583456     PISSN: 03069877     EISSN: 15322777     Source Type: Journal    
DOI: 10.1016/j.mehy.2012.05.034     Document Type: Article

References (19)

1. Ray S.K., Dixon C.E., Banik N.L. Molecular mechanisms in the pathogenesis of traumatic brain injury. Histol Histopathol 2002, 17:1137-1152.
2. Meyer K.S., Marion D.W., Coronel H., Jaffee M.S. Combat-related traumatic brain injury and its implications to military healthcare. Psychiatr Clin North Am 2010, 33:783-796.
3. Warden D. Military TBI during the Iraq and Afghanistan wars. J Head Trauma Rehabil 2006, 21:398-402.
4. Langlois J.A., Rutland-Brown W., Wald M.M. The epidemiology and impact of traumatic brain injury: a brief overview. J Head Trauma Rehabil 2006, 21:375-378.
5. Centers for Disease Control and Prevention (CDC). Nonfatal traumatic brain injuries from sports and recreation activities - United States, 2001-2005. MMWR Morb Mortal Wkly Rep 2007;56:733-737.
6. Choi S.C., Bullock R. Design and statistical issues in multicenter trials of severe head injury. Neurol Res 2001, 23:190-192.
7. Goll D.E., Thompson V.F., Li H., Wei W., Cong J. The calpain system. Physiol Rev 2003, 83:731-801.
8. Vosler P.S., Brennan C.S., Chen J. Calpain-mediated signaling mechanisms in neuronal injury and neurodegeneration. Mol Neurobiol 2008, 38:78-100.
9. Liu J., Liu M.C., Wang K.K. Calpain in the CNS: from synaptic function to neurotoxicity. Sci Signal 2008, 1:re1.
10. Marklund N., Hillered L. Animal modelling of traumatic brain injury in preclinical drug development: where do we go from here?. Br J Pharmacol 2011, 164:1207-1229.
11. Carragher N.O. Calpain inhibition: a therapeutic strategy targeting multiple disease states. Curr Pharm Des 2006, 12:615-638.
12. Kupina N.C., Nath R., Bernath E.E., et al. The novel calpain inhibitor SJA6017 improves functional outcome after delayed administration in a mouse model of diffuse brain injury. J Neurotrauma 2001, 18:1229-1240.
13. Higuchi M., Tomioka M., Takano J., et al. Distinct mechanistic roles of calpain and caspase activation in neurodegeneration as revealed in mice overexpressing their specific inhibitors. J Biol Chem 2005, 280:15229-15237.
14. Trinchese F., Fa' M., Liu S., et al. Inhibition of calpains improves memory and synaptic transmission in a mouse model of Alzheimer disease. J Clin Invest 2008, 118:2796-2807.
15. Anagli J., Han Y., Stewart L., et al. A novel calpastatin-based inhibitor improves postischemic neurological recovery. Biochem Biophys Res Commun 2009, 385:94-99.
16. Colak A., Kaya M., Karaoĝlan A., et al. Calpain inhibitor AK 295 inhibits calpain-induced apoptosis and improves neurologic function after traumatic spinal cord injury in rats. Neurocirugia (Astur) 2009, 20:245-254.
17. Frederick J.R., Chen Z., Bevers M.B., Ingleton L.P., Ma M., Neumar R.W. Neuroprotection with delayed calpain inhibition after transient forebrain ischemia. Crit Care Med 2008, 36(Suppl. 11):S481-S485.
18. Kawamura M., Nakajima W., Ishida A., Ohmura A., Miura S., Takada G. Calpain inhibitor MDL 28170 protects hypoxic-ischemic brain injury in neonatal rats by inhibition of both apoptosis and necrosis. Brain Res 2005, 1037:59-69.
19. Cox C.D., West E.J., Liu M.C., Wang K.K., Hayes R.L., Lyeth B.G. Dicyclomine, an M1 muscarinic antagonist, reduces biomarker levels, but not neuronal degeneration, in fluid percussion brain injury. J Neurotrauma 2008, 25:1355-1365.